Transcatheter Cardiovascular Therapeutics (TCT) Conference 2010: Review and Analysis

• Publication date: November 2011

The report provides key data and data on the products showcased in the conference. The report also provides answers to questions like: what are the emerging trends in the cardiovascular devices industry ? Which are the upcoming technologies and firms ? Which segments are expected to grow and why? What products are in pipeline and how would they impact segment growth? This report also provides an insight into key studies and trials being held, wit...

The report provides key data and data on the products showcased in the conference. The report also provides answers to questions like: what are the emerging trends in the cardiovascular devices industry ? Which are the upcoming technologies and firms ? Which segments are expected to grow and why? What products are in pipeline and how would they impact segment growth? This report also provides an insight into key studies and trials being held, with up-to date results and analysis.

Scope of the Research

- The report covers information and analysis on product and technology launched at the conference.
- Analysis and review of the key products and technologies within each sector and sub - sectors that will impact the future of cardiovascular devices.
- Review of key market trends and events which are likely to impact and change the dynamics of the global cardiovascular devices industry s in the long run.
- In-depth analysis of the studies and clinical trials presented at the conference.
- List of key industry players presenting at the conference with industry player and product profiles.
- The report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by Industry expert's team of market experts.

Why Should You Get This Report?

- Develop business strategies by understanding the trends shaping and driving the global cardiovascular devices industry .
- Organize your sales and industry ing efforts by identifying the prevalent and expected competitive landscape in different cardiovascular devices industry s.
- Design and develop your product development, industry ing and sales strategies by identifying the industry sectors poised for a strong growth.
- Identify key players who are best positioned to take advantage of the emerging industry opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
- What’s the next being thing in the cardiovascular devices industry landscape? – Identify, understand and decide.

Cardiovascular Devices Industry in the United States

1 Table of Contents 1
I. 1 List of Data tables 2
I. 2 List of Charts 2

II Summary 3
II. 1 Key Takeaways 3

III Transcatheter Cardiovascular Therapeutics (TCT) Conference 2010: Highlights 4
III. 1 PARTNER Study: All-Cause, Cardiovascular Mortality Lower in Patients Treated with Transcatheter Aortic Valve Implantation (TAVI) versus Standard Therapy at One Year 4
III. 2 ABSORB Trial: Bioabsorbable Stents Continue to Demonstrate Strong Clinical Outcomes 6
III. 3 Zilver PTX Trial: New Drug Eluting Stent Improves Patency and Safety Outcomes in Patients with Femoropopliteal Artery Disease 7
III. 4 Medtronic’s Resolute Drug Eluting Stent Exhibited Strong Clinical Performance 8
III. 5 SPIRIT IV and COMPARE Studies: Xience V Sustains Advantage over Taxus at Two Years 10
III. 6 Comparative Effectiveness Research: CYPHER Sirolimus-Eluting Coronary Stent in Patients with Diabetes would Result in Significant Cost Savings Compared to Other Stents 11
III. 7 Medtronic Announces Results from IN.PACT Drug-Eluting Balloon (DEB) Clinical Program and Future Clinical Studies 12
III. 8 LEVANT I and PERfECT Stent Studies Reiterate Positive Outcomes with Drug-Eluting Balloons 14
III. 8.1 LEVANT I Results 14
III. 8.2 PERfECT Stent Study Results 15
III. 9 TORPEDO Trial: Combined Therapy of Percutaneous Treatment and Anticoagulation Drugs for Deep Venous Thrombosis is Superior to Anticoagulation Drug Therapy Alone 15

IV Key Firms Presentations and their Products 16
IV. 1 Medtronic 16
IV. 1.1 Products Presented 16
IV. 2 St. Jude Medical 17
IV. 2.1 Product Presented: C7-XR(TM) OCT Intravascular Imaging System 17
IV. 3 GE Healthcare 17
IV. 3.1 Product Presented: Innova Vision Technologies 18
IV. 4 Volcano Corporation 18
IV. 4.1 Products Presented 18
IV. 5 Abiomed 19
IV. 5.1 Products Presented 19
IV. 6 Neovasc 20
IV. 6.1 Product Presented: Reducer 20
IV. 7 InfraReDx 20
IV. 7.1 Product Presented: LipiScan IVUS Coronary Imaging System 21
IV. 8 Cook Medical 21
IV. 8.1 Product Presented: Zilver PTX Drug Eluting Peripheral Stent 21
IV. 9 Corindus, Inc. 21
IV. 9.1 Product Presented: CorPath 200 System 22

V Appendix 23
V. 1 Research Methodology 23
V. 2 Secondary Research 24
V. 3 Primary Research 24
V. 4 Models 24
V. 5 Forecasted data s 25
V. 6 Expert Panels 25
V. 7 GlobalData Consulting 25
V. 8 Contact Us 25
V. 9 Disclaimer 25

1.1 List of Data tables
Data table 1: Transcatheter Aortic Valves March ket, Global, Sales (USD Million), 2009 – 2016 5
Data table 2: Coronary Stents March ket, Global, Sales ($bn), 2009 – 2016 7
Data table 3: Drug Eluting Stents March ket, Global, Sales ($bn), 2009 – 2016 9
Data table 4: Drug Eluting Balloons March ket, Global, Sales (USD Million), 2009 – 2016 13

1.2 List of Charts
Chart 1: Transcatheter Aortic Valves March ket, Global, Sales (USD Million), 2009 – 2016 4
Chart 2: Coronary Stents March ket, Global, Sales ($bn), 2009 – 2016 7
Chart 3: Drug Eluting Stents March ket, Global, Sales ($bn), 2009 – 2016 9
Chart 4: Drug Eluting Stents March ket, Global, Market Shares (%), 2009 11
Chart 5: Drug Eluting Balloons March ket, Global, Sales (USD Million), 2009 – 2016 13

Companies mentioned
Medtronic
St. Jude Medical
GE Healthcare
Volcano Corporation
Abiomed
Neovasc
InfraReDx
Cook Medical
Corindus, Inc.